EU To Get Four Million Extra Pfizer Doses For ‘Hotspots’

Files: JOEL SAGET / AFP

 

The EU will receive an extra four million BioNTech/Pfizer vaccine doses over the next two weeks to be deployed to Covid-19 “hotspots”, European Commission chief Ursula von der Leyen said Wednesday.

The delivery — over and above already agreed supplies from the vaccine-maker — will go to affected border regions within the bloc to “help ensure or restore free movement of goods and people,” she said in a statement.

The announcement came as von der Leyen’s commission attempted to persuade at least six member states — including her home country Germany — to lift virus-related border restrictions deemed by Brussels to be excessive.

It also follows a trip by the leaders of Austria and Denmark to Israel to form a vaccine-producing alliance that exemplified broad criticism of the lack of deliveries so far under the commission’s pre-purchasing scheme.

Von der Leyen said the four million extra BioNTech/Pfizer doses will be delivered “before the end of March” and will help member states deploy “their targeted use where they are most needed, in particular in border regions”.

She said they would go to “tackle aggressive variants of the virus and to improve the situation in hotspots”.

Von der Leyen pointed to steep rises in infections and hospitalisations in Austria’s Tyrol region, France’s Nice and Moselle regions, Bolzano in Italy, and parts of Germany’s Bavaria and Saxony regions.

Those had led to “stringent measures and even in certain cases to impose new border controls,” it said.

The statement noted that BioNTech/Pfizer’s mRNA vaccine was showing itself to be “highly effective” against the new variants.

It added that the four million extra doses would be made available for member states to buy on pro-rata basis according to their population size.

Von der Leyen called the additional agreement “quick and decisive action” on the part of her commission, and emphasised that restoring freedom of movement within the EU was “key for the functioning of health systems and the Single Market”.

AFP

US President-Elect Joe Biden Receives Second COVID-19 Vaccine Shot

WILMINGTON, DELAWARE – JANUARY 11: President-elect Joe Biden receives the second dose of the Pfizer/BioNTech COVID-19 vaccination from Chief Nurse Executive Ric Cuming at ChristianaCare Christiana Hospital on January 11, 2021. Alex Wong/Getty Images/AFP

 

President-elect Joe Biden on Monday received his second Covid-19 shot, and said that getting vaccines into people’s arms would be a “number one priority” for his incoming administration.

It comes as vaccine rollout has faltered badly in the world’s hardest-hit country, where some 375,000 people have died from the coronavirus and about 3,000 more are dying every day.

Some 25.5 million first doses of Covid vaccines have been shipped out to hospitals, clinics and nursing homes across the country, but only around 9 million have been injected, according to official data.

The 78-year-old incoming president arrived at the Christiana Hospital in Newark, Delaware in the early afternoon, removed his blazer, and thanked the nurse who injected his left arm with the second dose of the Pfizer vaccine.

READ ALSO: England Opens Mass Vaccination Sites As COVID-19 Spike Fears Spread

“My number one priority is getting vaccine in people’s arms, like we just did today, as rapidly as we can,” he told reporters, adding that he would be holding a virtual meeting with his coronavirus team later on, and announcing a new strategy on Thursday.

WILMINGTON, DELAWARE – JANUARY 11: President-elect Joe Biden puts on a mask after receiving his second dose of the Pfizer/BioNTech COVID-19 vaccination at ChristianaCare Christiana Hospital on January 11, 2021. Alex Wong/Getty Images/AFP

 

“Three to four thousand people a day dying is just beyond the pale… it’s wrong, and we can do a lot to change it.”

He emphasized the need to continue social distancing and mask wearing, and added that he was “appalled” that Republican lawmakers refused to wear masks when they were forced into a security lockdown during last week’s Capitol attack by supporters of President Donald Trump.

“I think it’s irresponsible. It’s not a political issue, it’s an issue of public safety.”

Biden has also pledged to push for more direct stimulus checks to taxpayers, and said he was speaking with Republican lawmakers about moving on a second package “sooner rather than later.”

Jordan Approves Pfizer-BioNTech COVID-19 Vaccine

In this file photo taken on November 23, 2020 is pictured a bottle reading “Vaccine Covid-19” next to US pharmaceutical company Pfizer and German biotechnology company BioNTech logos on November 23, 2020.
JOEL SAGET / AFP

 

Jordan announced late Monday that it had approved emergency use of the Pfizer-BioNTech coronavirus vaccine, as the United States kicked off a mass vaccination drive.

The Jordanian Food and Drug Administration (JFDA) did not specify when it would begin the rollout of the vaccine by US pharmaceutical giant Pfizer and its German partner BioNTech.

Health Minister Nazir Obeidat said last month that the vaccine would be distributed free of charge to foreign residents as well as Jordanians.

JFDA director-general Nizar Mheidat told the official Petra news agency it had “concluded all stages of granting the licence, in order to approve and distribute the vaccine”.

He added that a study was also underway to allow the use of two other vaccines.

Jordan has previously said it was in talks on the use of two other Covid vaccines being developed by British pharmaceuticals group AstraZeneca and US group Johnson & Johnson.

Jordan’s green light for the Pfizer vaccine follows those of Bahrain and Saudi Arabia and came six days after Britain launched the world’s first mass innoculation campaign using the vaccine.

The kingdom has recorded 262,477 Covid-19 cases in its population of just over 10 million, 3,407 of them fatal.

Last week, Jordan opened the first of three military field hospitals for Covid-19 patients, intended to prevent a sharp rise in cases from overwhelming existing healthcare facilities.

-AFP

US Approves Pfizer Vaccine As Millions Of Doses Begin Shipping

An illustration picture shows vials with Covid-19 Vaccine stickers attached, with the logo of US pharmaceutical company Pfizer, on November 17, 2020. JUSTIN TALLIS / AFP
An illustration picture shows vials with Covid-19 Vaccine stickers attached, with the logo of US pharmaceutical company Pfizer, on November 17, 2020.
JUSTIN TALLIS / AFP

 

The US green-lit the Pfizer-BioNTech Covid-19 vaccine late Friday, paving the way for millions of vulnerable people to receive their shots in the world’s hardest-hit country.

President Donald Trump immediately released a video on Twitter, where he hailed the news as a “medical miracle” and said the first immunizations would take place “in less than 24 hours.”

It comes as infections across America soar as never before, with the grim milestone of 300,000 confirmed deaths fast approaching.

The US is now the sixth country to approve the two-dose regimen, after Britain, Bahrain, Canada, Saudi Arabia, and Mexico.

The move came earlier than expected and capped a day of drama after it was widely reported that the White House had threatened to fire Food and Drug Administration chief Stephen Hahn if he did not grant emergency approval Friday.

Trump’s intervention reinserts politics into the scientific process, which some experts have said could undermine vaccine confidence.

The US is seeking to inoculate 20 million people this month alone, with long-term care facility residents and health care workers at the front of the line.

The government also said Friday that it is buying 100 million more doses of the Moderna vaccine candidate, amid reports the administration passed on the opportunity to secure more supply of the Pfizer jab.

The purchase brings its total supply of Moderna doses to 200 million, enough to immunize 100 million people with the two-shot regimen that could be approved as early as next week.

Both frontrunners are based on mRNA (messenger ribonucleic acid), a major victory for a technology that had never previously been proven.

Two other vaccine candidates stumbled Friday: France’s Sanofi and Britain’s GSK said their vaccine would not be ready until the end of 2021.

In Peru, clinical trials of a vaccine made by Chinese drug giant Sinopharm were suspended after neurological problems were detected in a test volunteer.

And in Australia the development of a vaccine at the University of Queensland was abandoned Friday after clinical trials produced a false positive HIV result among subjects involved in early testing.

 

READ ALSO: Peru Temporarily Suspends Clinical Trials Of Chinese COVID-19 Vaccine

– Sputnik mix –

The mixed news on the vaccine front came as infections accelerated fast in North America and parts of Africa but started to stabilize in Europe and drop in Asia and the Middle East.

Around the world, more than 1.58 million lives have been lost to Covid-19, according to an AFP tally from official sources.

Brazil on Friday crossed 180,000 deaths, despite President Jair Bolsonaro’s insistence the crisis was at the “tail end.”

But across the Pacific Ocean, New Zealand, which has been praised for its handling of the virus, took its first tentative steps towards reopening its borders with the tiny Cook Islands.

Less good news arrived in South Korea — a country previously held up as a model of how to combat the pandemic — which reported its highest daily number of new cases so far, with a surge centered around Seoul sparking fears the country could lose control of the spread.

Officials there announced 950 new infections after several days reporting numbers ranging from about 500 to 600.

And in China, where the virus first emerged a year ago but has since been brought under control, two cities on the border with Russia reported one local infection each, sparking mass tests in both and a full lockdown in one of them.

Countries that have approved the Pfizer-BioNTech jab meanwhile were preparing for rollout, as the World Health Organization warned of a potentially grim Christmas season.

Following Britain’s lead, the first vaccine shipments to 14 sites across Canada are scheduled to arrive Monday with people receiving shots a day or two later.

Israel, which accepted its first shipment of the Pfizer vaccine on Wednesday, is targeting a rollout on December 27.

And Hong Kong said Friday it had struck deals for two vaccines — one from Pfizer and the other from Beijing-based Sinovac — with plans to launch a campaign in early 2021.

A new combined approach is also being tested by AstraZeneca, whose Russian operation said it would mix its shot with the locally-made Sputnik V vaccine in clinical trials.

Russia and China have already begun inoculation efforts with domestically produced vaccines that have seen less rigorous vetting.

EU countries are eagerly awaiting clearance on the Pfizer and Moderna vaccines, in late December and early January respectively.

– Carbon down –

As Europe’s surge eases off slightly, France is planning to lift a six-week lockdown from Tuesday but impose a curfew from 8.00 pm, including on New Year’s Eve.

Greece also announced new plans Friday to slash quarantine time for incoming travelers and reopen churches for Christmas.

But Switzerland, which is seeing a sharp resurgence in cases, announced a 7:00 pm curfew for shops, restaurants and bars.

While lockdowns have brought economic pain, boredom, and myriad other woes, the effect on the environment have been more positive.

Carbon emissions fell a record seven percent in 2020 as countries imposed lockdowns, according to the Global Carbon Project.

AFP